The Coalition for Pulmonary Fibrosis (CPF) has partnered with the American Thoracic Society (ATS) to jointly fund a $100,000, 2-year research grant to be awarded in January 2007.

The American Thoracic Society/Coalition for Pulmonary Fibrosis Partnership Research Award in Pulmonary Fibrosis will be awarded to a US-based investigator working on translational studies in pulmonary fibrosis and will be granted by the ATS Scientific Advisory Committee through a rigorous peer-review application process. The initial deadline for applications is Monday, June 19, 2006.

“The need for improved funding for IPF-related research can only be met through partnerships such as this,” said Marvin I. Schwarz, MD, chairman of the CPF and professor at the James C. Campbell Pulmonary Medicine Department at the University of Colorado Health Sciences Center in Denver. “We are proud to partner with the ATS and pool our resources to make such a grant available. The ATS Research Program has a longstanding record of achievement in funding emerging research in interstitial lung diseases, and we are excited to jointly fund new research efforts in pulmonary fibrosis.”

“By stimulating research in pulmonary fibrosis, our new partnership has great potential to discover new ways to improve the treatment of patients with this disabling disease,” said Thomas R. Martin, MD, past president of ATS and chair of the ATS Research Program.  “Partnerships like this between scientific and patient-oriented organizations bring a new vitality and a heightened sense of urgency to the research process, which is sure to benefit patients.”

Potential applicants should submit a letter of intent using the Letter-of-Intent (LOI) application that is downloadable from the ATS website located at [removed]http://www.thoracic.org/sections/research/new-research-program.html[/removed]. Letters of intent should be submitted via the ATS website by 11 pm EDT on Monday, June 19, 2006.